×
× Digital News Videos Opinion Special Reports Lifestyle Weird News Health & Science Education Columns The Hague Trial Kenya @ 50 Comand Your Morning E-Paper Lifestyle & Entertainment Nairobian Entertainment Eve Woman Travelog TV Stations KTN Home KTN News BTV KTN Farmers TV Radio Stations Radio Maisha Spice FM Vybez Radio Enterprise VAS E-Learning Digger Classified The Standard Group Corporate Contact Us Rate Card Vacancies DCX O.M Portal Corporate Email RMS
×

Ministry to evaluate Catholic church claims over cancer vaccine

By Graham Kajilwa | September 12th 2019 at 12:00:00 GMT +0300

Health Cabinet Secretary Sicily Kariuki when she appeared before the National Assembly Health Committee at Protection House, Nairobi. [Boniface Okendo/Standard]

The Ministry of Health is evaluating a report by doctors affiliated to the Catholic church over the yet-to-be rolled out cancer vaccine.

Health Cabinet Secretary Sicily Kariuki (pictured) confirmed that the report had reached her office.

The CS spoke at the end of East Africa Healthcare Federation Conference yesterday.

The Kenya Catholic Doctors Association (KCDA) has been against the roll-out of Human Papilloma Virus (HPV vaccine which is meant to protect women against cervical cancer.

The doctors did their research on why the vaccine should not be administered on 10-year-old children as planned by the Government.

The association argued that there are numerous studies that have concluded that the vaccine is harmful and should not be administered on the targeted population, more so because the girls are yet to be sexually-active.

But Health CS said the Government in its wisdom cannot introduce something that is harmful to its citizens.

“I have never seen a government that careless. This is a vaccine that has undergone a lot of research,” she said.

The CS said the Government is out to protect its citizens. Though breast is the leading cancer in the country among women, cervical cancer leads in terms of mortality, according to the 2018 Globocan report.


THE STANDARD INSIDER

Read More

Feedback